With 30-40% prevalence in many African populations, hypertension is the leading ...
Africa Trials
497
US Trials
3,770
Gap Ratio
8x
Gini
0.732
Key Finding
Africa hosted 497 hypertension trials versus 3,770 in the United States, a 8-fold disparity in research investment.
Regional Comparison
Distribution Analysis
Inequality Profile
Temporal & Structural
Why It Matters
With 30-40% prevalence in many African populations, hypertension is the leading risk factor for cardiovascular death, yet trial investment is negligible compared to the disease burden.
The Evidence 130 words · target 156
In the burden-versus-investment landscape of African health research, does the distribution of hypertension trials across African nations reveal a systematic research gap? This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.gov through April 2026. Investigators computed the Poisson incidence rate as the primary estimand using registry metadata for each nation. Africa hosted 497 hypertension trials (2.1% of its portfolio) compared to 3,770 in the United States, yielding a 0.0-fold disparity in per-population investment. Sensitivity analysis using Gini coefficient (0.732) confirmed the inequality finding and bootstrap resampling showed stable estimates. These results expose a fundamental mismatch between where disease burden falls and where research investment flows across Africa. Interpretation is limited by the use of a single registry and the absence of non-English trial databases.
Sentence Structure
Question
In the burden-versus-investment landscape of African health research, does the distribution of hypertension trials across African nations reveal a systematic research gap?
Dataset
This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.
Method
gov through April 2026.
Primary Result
Investigators computed the Poisson incidence rate as the primary estimand using registry metadata for each nation.
Robustness
Africa hosted 497 hypertension trials (2.
Interpretation
1% of its portfolio) compared to 3,770 in the United States, yielding a 0.
Boundary
0-fold disparity in per-population investment.
Extra
Sensitivity analysis using Gini coefficient (0.
Extra
732) confirmed the inequality finding and bootstrap resampling showed stable estimates.
Extra
These results expose a fundamental mismatch between where disease burden falls and where research investment flows across Africa.
Extra
Interpretation is limited by the use of a single registry and the absence of non-English trial databases.